Erika Toth

11PUBLICATIONS
59CO-AUTHORS
Solid tumoursGene expression (incl. microarray and other genome-wide approaches)Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|May 11, 2026
Superficial SOX10/S100 positive EWSR1::FLI1 fusion tumour with aggressive behaviour.

|Dec 11, 2025
Processed Transcript Insertion as a Novel Germline Mutational Mechanism in <i>BRCA1</i>-Associated Hereditary Breast Cancer.

Anikó Bozsik, Henriett Butz, Vince Kornél Grolmusz

|Jul 12, 2025
Defactinib in Combination with Mitotane Can Be an Effective Treatment in Human Adrenocortical Carcinoma.

Henriett Butz, Lőrinc Pongor, Lilla Krokker

|Jul 04, 2025
Comprehensive genomic profiling and immunohistochemical analysis of prepubertal-type testicular neuroendocrine tumours in postpubertal patients reveal a possible relationship with small intestinal neuroendocrine tumours.

Luca Szalai, Maja Leiner, Erika Tóth

|Jan 08, 2025
Tumor-Infiltrating Immune Cells and HLA Expression as Potential Biomarkers Predicting Response to PD-1 Inhibitor Therapy in Stage IV Melanoma Patients.

Barbara Hegyi, Kristóf György Csikó, Tímea Balatoni

|Nov 09, 2024
Glucocorticoid Receptor Isoforms in Breast Cancer Raise Implications for Personalised Supportive Therapies.

Henriett Butz, Viktória Vereczki, Barna Budai

Pageof 2

Frequent Collaborators

3 joint publications

Andrea Kohanka

3 joint publications

Henriett Butz

3 joint publications

Attila Patócs

2 joint publications

Zsombor Melegh